108 related articles for article (PubMed ID: 2766721)
1. Risk factors for breast fibroadenoma in young women.
Sitruk-Ware R; Thalabard JC; Benotmane A; Mauvais-Jarvis P
Contraception; 1989 Sep; 40(3):251-68. PubMed ID: 2766721
[TBL] [Abstract][Full Text] [Related]
2. Cyclical mastalgia as a marker of breast cancer susceptibility: results of a case-control study among French women.
Plu-Bureau G; Thalabard JC; Sitruk-Ware R; Asselain B; Mauvais-Jarvis P
Br J Cancer; 1992 Jun; 65(6):945-9. PubMed ID: 1616869
[TBL] [Abstract][Full Text] [Related]
3. Breast cancer among young U.S. women in relation to oral contraceptive use.
White E; Malone KE; Weiss NS; Daling JR
J Natl Cancer Inst; 1994 Apr; 86(7):505-14. PubMed ID: 8133534
[TBL] [Abstract][Full Text] [Related]
4. Oral contraceptive use and risk of benign breast disease in a French case-control study of young women.
Charreau I; Plu-Bureau G; Bachelot A; Contesso G; Guinebretiére JM; Lê MG
Eur J Cancer Prev; 1993 Mar; 2(2):147-54. PubMed ID: 8461865
[TBL] [Abstract][Full Text] [Related]
5. The role of reproductive factors and use of oral contraceptives in the aetiology of breast cancer in women aged 50 to 74 years.
Magnusson CM; Persson IR; Baron JA; Ekbom A; Bergström R; Adami HO
Int J Cancer; 1999 Jan; 80(2):231-6. PubMed ID: 9935204
[TBL] [Abstract][Full Text] [Related]
6. Oral contraceptive use and early abortion as risk factors for breast cancer in young women.
Pike MC; Henderson BE; Casagrande JT; Rosario I; Gray GE
Br J Cancer; 1981 Jan; 43(1):72-6. PubMed ID: 7459241
[TBL] [Abstract][Full Text] [Related]
7. Oral contraceptives and breast cancer risk in Taiwan, a country of low incidence of breast cancer and low use of oral contraceptives.
Chie WC; Li CY; Huang CS; Chang KJ; Yen ML; Lin RS
Int J Cancer; 1998 Jul; 77(2):219-23. PubMed ID: 9650556
[TBL] [Abstract][Full Text] [Related]
8. Oral contraceptives and breast cancer.
Brinton LA; Hoover R; Szklo M; Fraumeni JF
Int J Epidemiol; 1982 Dec; 11(4):316-22. PubMed ID: 7152784
[TBL] [Abstract][Full Text] [Related]
9. Oral contraception and breast pathology.
Ragni N; Boccardo E; Viglino S; Larosa E
Acta Eur Fertil; 1981 Jun; 12(2):141-63. PubMed ID: 6794288
[TBL] [Abstract][Full Text] [Related]
10. Comparative profiles of reliability, cycle control and side effects of two oral contraceptive formulations containing 150 micrograms desogestrel and either 30 micrograms or 20 micrograms ethinyl oestradiol.
Akerlund M; Røde A; Westergaard J
Br J Obstet Gynaecol; 1993 Sep; 100(9):832-8. PubMed ID: 8218004
[TBL] [Abstract][Full Text] [Related]
11. Oral contraceptives and risk of breast cancer.
Paul C; Skegg DC; Spears GF
Int J Cancer; 1990 Sep; 46(3):366-73. PubMed ID: 2394503
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for breast cancer in women undergoing mammography.
Reuter KL; Baker SP; Krolikowski FJ
AJR Am J Roentgenol; 1992 Feb; 158(2):273-8. PubMed ID: 1729780
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for fibroadenoma: a case-control study in Australia.
Yu H; Rohan TE; Cook MG; Howe GR; Miller AB
Am J Epidemiol; 1992 Feb; 135(3):247-58. PubMed ID: 1546700
[TBL] [Abstract][Full Text] [Related]
14. Population-based study of risk of venous thromboembolism associated with various oral contraceptives.
Farmer RD; Lawrenson RA; Thompson CR; Kennedy JG; Hambleton IR
Lancet; 1997 Jan; 349(9045):83-8. PubMed ID: 8996419
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for pathologically confirmed benign breast disease.
Parazzini F; La Vecchia C; Franceschi S; Decarli A; Gallus G; Regallo M; Liberati A; Tognoni G
Am J Epidemiol; 1984 Jul; 120(1):115-22. PubMed ID: 6741913
[TBL] [Abstract][Full Text] [Related]
16. Clinical and metabolic study of a new pill containing 20 mcg ethinylestradiol plus 0.150 mg desogestrel.
Fioretti P; Fruzzetti F; Navalesi R; Ricci C; Miccoli R; Cerri M; Orlandi MC; Melis GB
Contraception; 1987 Mar; 35(3):229-43. PubMed ID: 2956055
[TBL] [Abstract][Full Text] [Related]
17. Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.
Narod SA; Dubé MP; Klijn J; Lubinski J; Lynch HT; Ghadirian P; Provencher D; Heimdal K; Moller P; Robson M; Offit K; Isaacs C; Weber B; Friedman E; Gershoni-Baruch R; Rennert G; Pasini B; Wagner T; Daly M; Garber JE; Neuhausen SL; Ainsworth P; Olsson H; Evans G; Osborne M; Couch F; Foulkes WD; Warner E; Kim-Sing C; Olopade O; Tung N; Saal HM; Weitzel J; Merajver S; Gauthier-Villars M; Jernstrom H; Sun P; Brunet JS
J Natl Cancer Inst; 2002 Dec; 94(23):1773-9. PubMed ID: 12464649
[TBL] [Abstract][Full Text] [Related]
18. Oral contraceptives in relation to breast cancer.
Malone KE; Daling JR; Weiss NS
Epidemiol Rev; 1993; 15(1):80-97. PubMed ID: 8405215
[TBL] [Abstract][Full Text] [Related]
19. Breast cancer in young women and use of oral contraceptives: possible modifying effect of formulation and age at use.
Pike MC; Henderson BE; Krailo MD; Duke A; Roy S
Lancet; 1983 Oct; 2(8356):926-30. PubMed ID: 6138501
[TBL] [Abstract][Full Text] [Related]
20. Early oral contraceptive use and breast cancer among premenopausal women: final report from a study in southern Sweden.
Olsson H; Möller TR; Ranstam J
J Natl Cancer Inst; 1989 Jul; 81(13):1000-4. PubMed ID: 2733043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
